Literature DB >> 17828816

Memory CD8+ T cell differentiation in viral infection: a cell for all seasons.

Henry Radziewicz1, Luke Uebelhoer, Bertram Bengsch, Arash Grakoui.   

Abstract

Chronic viral infections such as hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are major global health problems affecting more than 500 million people worldwide. Virus-specific CD8+ T cells play an important role in the course and outcome of these viral infections and it is hypothesized that altered or impaired differentiation of virus-specific CD8+ T cells contributes to the development of persistence and/or disease progression. A deeper understanding of the mechanisms responsible for functional differentiation of CD8+ T cells is essential for the generation of successful therapies aiming to strengthen the adaptive component of the immune system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828816      PMCID: PMC4611763          DOI: 10.3748/wjg.v13.i36.4848

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  78 in total

Review 1.  The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance.

Authors:  Terry J Fry; Crystal L Mackall
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

2.  PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver.

Authors:  Holly Maier; Masanori Isogawa; Gordon J Freeman; Francis V Chisari
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

3.  Dynamics of T cell responses in HIV infection.

Authors:  Victor Appay; Laura Papagno; Celsa A Spina; Pokrath Hansasuta; Abigail King; Louise Jones; Graham S Ogg; Susan Little; Andrew J McMichael; Douglas D Richman; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 4.  Human virus-specific CD8+ T cells: diversity specialists.

Authors:  Ester M M van Leeuwen; Godelieve J de Bree; Ineke J M ten Berge; René A W van Lier
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

5.  Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load.

Authors:  A Oxenius; H F Günthard; B Hirschel; S Fidler; J N Weber; P J Easterbrook; J I Bell; R E Phillips; D A Price
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

6.  Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.

Authors:  Henry Radziewicz; Chris C Ibegbu; Marina L Fernandez; Kimberly A Workowski; Kamil Obideen; Mohammad Wehbi; Holly L Hanson; James P Steinberg; David Masopust; E John Wherry; John D Altman; Barry T Rouse; Gordon J Freeman; Rafi Ahmed; Arash Grakoui
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

7.  CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained.

Authors:  F Lechner; N H Gruener; S Urbani; J Uggeri; T Santantonio; A R Kammer; A Cerny; R Phillips; C Ferrari; G R Pape; P Klenerman
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

8.  Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells.

Authors:  Michaela Lucas; Ana L Vargas-Cuero; Georg M Lauer; Eleanor Barnes; Christian B Willberg; Nasser Semmo; Bruce D Walker; Rodney Phillips; Paul Klenerman
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

9.  Virus-specific CD8+ T-cell memory determined by clonal burst size.

Authors:  S Hou; L Hyland; K W Ryan; A Portner; P C Doherty
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

10.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Immunological battlefield in gastric cancer and role of immunotherapies.

Authors:  Minyu Wang; Rita A Busuttil; Sharon Pattison; Paul J Neeson; Alex Boussioutas
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

2.  Programmed death-1 expression is associated with the disease status in hepatitis B virus infection.

Authors:  Pian Ye; Zhi-Hong Weng; Shu-Ling Zhang; Jian-Ao Zhang; Lei Zhao; Ji-Hua Dong; Sheng-Hua Jie; Ran Pang; Rong-Hua Wei
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

3.  Viral hepatitis prevalence in patients with active and latent tuberculosis.

Authors:  Hesam Ahmadi Nooredinvand; David W Connell; Mahmoud Asgheddi; Mohammed Abdullah; Marie O'Donoghue; Louise Campbell; Melissa I Wickremasinghe; Ajit Lalvani; Onn Min Kon; Shahid A Khan
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

4.  Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.

Authors:  Odin Goovaerts; Wim Jennes; Marguerite Massinga-Loembé; Pascale Ondoa; Ann Ceulemans; Chris Vereecken; William Worodria; Harriet Mayanja-Kizza; Robert Colebunders; Luc Kestens
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

5.  Cytomegalovirus-Specific T Cells Restricted by HLA-Cw*0702 Increase Markedly with Age and Dominate the CD8+ T-Cell Repertoire in Older People.

Authors:  Louise Hosie; Annette Pachnio; Jianmin Zuo; Hayden Pearce; Stanley Riddell; Paul Moss
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

6.  Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infection.

Authors:  Aixin Song; Yisi Liu; Zhenhuan Cao; Junfeng Lu; Shan Ren; Sujun Zheng; Lina Ma; Zhongjie Hu; Xiao Lin; Hong Li; Yanhong Zheng; Xinyue Chen
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

7.  Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics.

Authors:  Rohan Sivapalan; Jinyan Liu; Krishnendu Chakraborty; Elisa Arthofer; Modassir Choudhry; Philip S Barie; Dan H Barouch; Tom Henley
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

8.  Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease.

Authors:  Rafael J Argüello; María C Albareda; María G Alvarez; Graciela Bertocchi; Alejandro H Armenti; Carlos Vigliano; Patricia C Meckert; Rick L Tarleton; Susana A Laucella
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

9.  Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness.

Authors:  Luke Uebelhoer; Jin-Hwan Han; Benoit Callendret; Guaniri Mateu; Naglaa H Shoukry; Holly L Hanson; Charles M Rice; Christopher M Walker; Arash Grakoui
Journal:  PLoS Pathog       Date:  2008-09-05       Impact factor: 6.823

10.  Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy.

Authors:  Sara Valpione; Elena Galvani; Joshua Tweedy; Piyushkumar A Mundra; Antonia Banyard; Philippa Middlehurst; Jeff Barry; Sarah Mills; Zena Salih; John Weightman; Avinash Gupta; Gabriela Gremel; Franziska Baenke; Nathalie Dhomen; Paul C Lorigan; Richard Marais
Journal:  Nat Cancer       Date:  2020-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.